mother and the new-born. There is also a risk of premature birth, vertical transmission causing neonatal thrombocytopenia, and foetal death. 4, 5 Laboratory diagnostic methods for confirming dengue infection may involve detection of the virus, viral nucleic acid, antigens or antibodies, or a combination of these techniques.
METHODS
All serologically diagnosed pregnant women treated for dengue infection during a 6-month period (June to November, 2017) at a tertiary care hospital in India were included.
Inclusion criteria
• All serologically diagnosed pregnant women (antenatal, intra-partum, and immediate post-partum) diagnosed with dengue infection were included in the study • Rapid NS-1 antigen detection test and serological test for detection of antibodies was used to confirm the diagnosis. Serological diagnosis depends on the presence of IgM antibody or a rise in IgG antibody titre in paired acute and convalescent phase serum.
Exclusion criteria
• Patients with febrile illness other than dengue infection, and with pre-existing medical disorders including hematological disorders, were excluded.
Clinical data, laboratory findings, and maternal and foetal outcomes were documented prospectively during their hospital stay. The cases were followed up daily for their clinical and laboratory parameters. Laboratory parameters that were followed up included a complete hemogram with haematocrit, total leucocyte count, and manual platelet count. Extra investigations (liver function tests, renal function tests etc.) were done whenever deemed necessary.
Grading of the severity of dengue infections was done according to 2009 World Health Organization (WHO) criteria. 2 Cases were classified as:
• Dengue without warning signs • Dengue with warning signs (abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, increasing haematocrit with decreasing platelets); and • Severe dengue (dengue with severe plasma leakage, severe bleeding, or organ impairment).
Analysis
Cases were evaluated based on the fall in platelet count, rise in haematocrit, presence of haemorrhagic manifestations or fluid leak in the mother, need for admission to an intensive care unit, need for platelet transfusion, the mode of delivery and the foeto-maternal outcome. The results were obtained and tabulated in an excel sheet. Data was then analysed manually.
The study protocol was approved by the Institutional Review Board. An informed consent was obtained from all the patients included in the study.
RESULTS
Twelve pregnant women were diagnosed with dengue infection during the study period. Their clinical and laboratory findings are shown in Table 1 .
Two patients (16.66%) presented in the first trimester of pregnancy, three (25%) in the second, six (50%) in the third trimester, while one (8.33%) presented in immediate post-partum period.
Three women (25%) developed severe dengue, while the remaining nine (75%) belonged to the category of Dengue with presence of warning signs. Thrombocytopenia, coupled with raised haematocrit were seen in all cases.
Conservative management in the form of hydration, antipyretic drugs, supportive care, and close monitoring of clinical condition and laboratory findings were sufficient in all cases of uncomplicated dengue infection. There was no place for prophylactic platelet transfusion, even in cases with severe thrombocytopenia. Platelet transfusion was needed only in cases with bleeding manifestations (3 out of 12 cases i.e. 25%). Three patients (25%) needed admission to an intensive care unit for management. A total 9 out of the total 12 (75%) cases were managed without any complications. The most common presenting complaints were fever and myalgia. Maternal and foetal outcomes were satisfactory in all of these cases.
Three cases (25%) presented with severe dengue, and developed complications in the form of ARDS causing death, bleeding, and encephalitis respectively. A few details about these three cases are mentioned below.
Case #10 was a 25-year-old woman, G2P1L1, 23 weeks gestation, referred from another hospital in a critical and intubated state. Patient was hospitalised earlier with complaints of fever with chills, and was diagnosed with dengue infection (platelet count -30,000/cumm). She developed breathlessness at the hospital, with ultrasound of thorax suggestive of left lung consolidation. She deteriorated over the day, needed intubation, and was transferred to our centre for specialized intensive care management. Patient was received in a compromised state. (Pulse -130/min; BP -100/60 mmHg; SpO2 -57%). She was given 8 units of platelet and 2 units of packed cell transfusion. Ultrasound scan was suggestive of intrauterine foetal demise. Induction of labour was done with . While the patient gave no history of fever prior to admission, on day 3 postdelivery, she developed high grade fever associated with chills and body ache. Investigations confirmed a dengue infection, with a platelet count of 49,000/cumm. The next day, she developed swelling at the episiotomy site, which was tense, tender and pitting on examination, suggestive of a hematoma with increasing size. Anticoagulation was stopped. The patient was visibly pale with a haemoglobin of 5.7 gm%. She was posted for drainage in the operation theatre for hematoma evacuation. Post-surgery, she was shifted to ICU for close monitoring of vitals. She received 5 units of packed cells, and 12 units of platelet transfusion. Once bleeding stopped completely and patient stabilized, she was shifted out of the ICU. Drainage site was left to be healed with secondary intention. Patient was discharged on 14 th day postdelivery. She was followed up later regarding the need for re-starting thromboprophylaxis.
Case #12 was a 30-year-old woman, G3P2L2, 39 weeks gestation, transferred from a secondary centre in view of dengue fever with thrombocytopenia (platelet count-67,000). She underwent an emergency caesarean in view of second stage arrest with meconium stained liquor. There was excessive intra-operative bleeding, for which a bilateral internal iliac artery ligation had to be done. In the ICU, on day 1 post-surgery, she had an episode of generalized tonic clonic convulsion. Neurology opinion was sought, and patient was started on injection Levetiracetam. The patient was conscious, but violent and non-cooperative. MRI was suggestive of features of encephalitis. Patient received 5 units of packed cell and 16 units FFPs in total. She was monitored in the ICU, on intra-venous antibiotics, steroids and supportive care. Her neurological status gradually improved and as she stabilized, she was shifted out of ICU.
Foetal outcomes were satisfactory in all but one of the pregnancies (8.33%), which had foetal demise. There were no cases suggestive of vertical transmission causing anomalies or need for platelet transfusions in the neonate due to bleeding manifestations. Routine screening using dengue-specific IgM antibodies in cord blood or serum for vertical transmission was not performed due to financial constraints.
All the women and new-borns who were discharged from the hospital were reviewed in postnatal clinics and paediatric clinics. None of the babies showed clinical evidence of ill health (including bleeding manifestations) or failure to thrive.
DISCUSSION
Dengue is a major public health problem in tropical countries. We encountered 12 cases of seropositive dengue infection in pregnancy during our study period at a tertiary hospital in India. There are several reports of dengue infection in pregnancy from literature review ( Table 2 ). The severity of the clinical picture varies as evident in Table 2 . Symptoms of infected women often differ. In general, the most common symptoms include fever, myalgia and arthralgia. 14 Fluid leakage (elevated haematocrit, pleural effusion or ascites) and hemorrhagic manifestations are characteristic features of dengue hemorrhagic fever, however, the physiological hemodilution of normal pregnancy can mask the hemoconcentration in dengue. 6 It is well proven that sequential infection with different dengue serotypes predisposes to more severe forms of the disease. This is explained by enhancement of the crossreactive cascade of amplified non-neutralizing heterologous antibodies, cytokines (higher levels of TNFα, IFN-γ) and complement activation causing endothelial dysfunction, platelet destruction and consumptive coagulopathy. [15] [16] [17] Adverse foetal outcomes may be attributed to the effects on placental circulation caused by endothelial damage with increased vascular permeability leading to plasma leakage. 5, 15 In our study of 12 cases, we observed maternal complications like thrombocytopenia, bleeding, encephalitis, and acute respiratory distress syndrome causing maternal death. Foetal outcomes were satisfactory in all but one case, which had intra-uterine foetal demise.
The study is limited by the diagnostic tests that were used for detecting dengue infection. The widely available clinical diagnostic test (the method used for the study) for investigating dengue is the rapid strip test with a sensitivity and specificity of ≈90%. The capture ELISA tests are comparatively more sensitive and specific (≈ 95% and 100% respectively). Therefore, our study might have underestimated the actual outcomes. None of the kits mentioned above has the ability to differentiate between the serotypes. On the other hand, the gold standard, reverse transcriptase PCR using type-specific primers is highly sensitive and specific. It is only positive during the acute phase and becomes negative shortly after defervescence, so the detection window in the clinical setup to confirm infection is relatively narrow. 18
CONCLUSION
Dengue in pregnancy requires early diagnosis and treatment. Early diagnosis is made difficult by the ambiguity of clinical findings and physiological changes of pregnancy that may confuse the clinician. A high index of clinical suspicion is, therefore, essential in any pregnant female with fever during epidemics. Pregnancies complicated by dengue infection require close monitoring for potential maternal and foetal complications. Conservative medical and obstetric management is the treatment of choice. Platelet transfusion is needed only in cases complicated by haemorrhagic manifestations.
Further studies and systematic reviews are mandatory as evidence-based data in the management specific for pregnant patients are inadequate.
